Free Consultation 215.567.2010

Yearly Archives: 2015

Caesar Rivise Obtains Federal Circuit Affirmance of a Denial of a Motion for Preliminary Injunction

Posted on Mar 13, 2015 in News

On March 12, 2015, the United States Court of Appeals for the Federal Circuit ruled in favor of Caesar Rivise clients Camber Pharmaceuticals, Inc. and InvaGen Pharmaceuticals, Inc. in a case filed by Roxane Laboratories, Inc. alleging infringement of its patent covering calcium acetate capsules and their use in the treatment of hyperphosphatemia in patients with chronic kidney disease.

Read More

Caesar Rivise Client Katy C. Worrilow, Ph.D., Founder and CEO of LifeAire Systems, Named Entrepreneur of the Year

Posted on Mar 12, 2015 in News

Katy C. Worrilow, Ph.D., Founder and CEO of LifeAire Systems, has been named Entrepreneur of the Year by the Lehigh Valley Economic Development Corporation (LVEDC) and will be presented with the award during LVEDC’s 2015 Annual Investors Meeting and Awards ceremony on March 18th.

Read More

Standards-Setting Body in the IP News Over Policy Change

Posted on Feb 25, 2015 in Articles

If someone does not have a technical background, then he or she may have never heard of the Institute of Electrical and Electronics Engineers, but IEEE plays a huge role in many of the most popular electronic devices that are used today. IEEE, of which I am a proud member, is the world’s largest association of technical professionals, with more than 400,000 members worldwide. IEEE has recently been in the news because of a significant policy change that will affect the patent rights of many patent holders. In fact, the policy change has initiated significant controversy, because while some technology users will benefit from this change, some patent owners have expressed not only dismay and concern, but outright defiance.

Read More

Hague Agreement Adoption by U.S. Will Reduce Barriers to Global Protection of Designs

Posted on Feb 23, 2015 in Blog

U.S. applicants interested in protecting their designs outside the U.S. will soon have the option of filing a single international design patent application under the Hague Agreement. The Hague Agreement goes into effect in the U.S. on May 13, 2015.

Read More

特許が「質」と定義される意味とは?

Posted on Jan 28, 2015 in Articles

クライアントに業務を取り扱う弁護士に何を期待するか尋ねてみてください。その答えは、業務に「質」が伴うことでしょう。誰でも、法律サービスを購入すると、代わりに質を手に入れると考えます。しかし、特許の分野において、特許が質を持つ意味とは何ですか?

Read More

What Does It Mean for a Patent to Be Defined as ‘Quality’?

Posted on Jan 28, 2015 in Articles

Ask any client what he or she expects from the lawyers who are handling his or her work, and invariably the answer you receive is that the work must possess “quality.” Everyone wants to know that when they purchase legal services, they will get quality in return. But in the patent realm, what does it mean for a patent to have quality?

Read More

Use of Data Analysis Tools by Caesar Rivise Attorneys Featured in National Legal Periodical Article

Posted on Jan 27, 2015 in News

Caesar Rivise Managing Partner, David Tener, is featured in an article relating to the firm’s use of Patent Advisor, a data analysis tool for patent prosecution in the U.S. Patent and Trademark Office. Attorneys at the firm use Patent Advisor to analyze the performance statistics of examiners when formulating a prosecution strategy for firm clients.

Read More

U.S. Buyers and Their Legal Advisors Beware: Indian Court’s Injunction Against Glenmark’s Continued Infringement of Symed Lab’s Process Patent Suggests That Pharmaceutical Method Claims Are Becoming More Readily Enforceable in India

Posted on Jan 23, 2015 in Blog

An ad interim injunction passed by the Honorable Delhi High Court (on January 19, 2015) against Glenmark restrained infringement of Symed’s Process Patent Nos. IN 213062 and IN 213063.

Read More

Supreme Court in Teva v. Sandoz Holds That Claim Construction Facts Must Be Reviewed Under Clear Error Standard On Appeal

Posted on Jan 20, 2015 in Blog

On Tuesday, January 20, 2015, in Teva Pharmaceuticals USA Inc. et al. v. Sandoz Inc. et al., case number 13-854, the United States Supreme Court, in a 7-2 decision by Justice Breyer abolished the CAFC’s en banc practice that claim construction rulings of the district court be reviewed de novo. Instead, the Court ruled that these ruling must be entitled to deference of the district court’s factual findings as Teva had requested in a dispute regarding its highly profitable Copaxone product for multiple sclerosis.

Read More

Philadelphia

1635 Market Street, 12th Floor
Philadelphia, Pennsylvania 19103-2212

215-567-2010 | 215-751-1142

View Map

Delaware

King Street Plaza - Suite 304. 800 N. King Street
Wilmington, Delaware 19801

302-544-9100 | 302-544-9103

View Map

Lehigh Valley

2030 Tilghman Street, Suite 201A
Allentown, Pennsylvania 18104-4399

610-255-7551 | 610-255-7542

View Map